Journal of translational medicine · 2025
Asymptomatic vivax malaria is associated with an IFN-γ-program on adaptive immunity.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Almeida Gregório Guilherme, Costa Camila Medeiros, Costa Pedro Augusto Carvalho, Gomes Gabriela Ribeiro, Figueiredo Maria Marta, Torres Katherine Jéssica, de Carvalho Alex Fiorini, Valiate Bruno Vinícius Santos, Sampaio Julia Ramos, Carvalho Brener Cunha, Pereira Dhelio Batista, Martines Alexia, Tada Mauro Shugiro, Soares Irene Silva, Ponmattam Jamie, Castro Marcia Caldas de, Golenbock Douglas Taylor, Gazzinelli Ricardo Tostes, Antonelli Lis Ribeiro do Valle
Аннотация
The adaptive immunity against Plasmodium vivax is thought to be essential to limit parasite growth during asymptomatic malaria, preventing the occurrence of symptoms. However, the mechanisms governing clinical immunity during asymptomatic infections are not understood. Here, we investigated the adaptive cellular compartment in asymptomatic P. vivax-infected individuals (ASY) compared to symptomatic patients (SY) and healthy donors (CTL). Our integrative analysis revealed a TH1-biased immune signature with expanded populations of TH1 CD4+ T cells associated with the asymptomatic infection. In addition, there is an expanded population of proliferating atypical memory B cells that correlate with IgG levels against P. vivax antigens and parasitemia. The absence of systemic inflammation based on a comprehensive panel of soluble markers and the lower expression of some regulatory markers suggests a controlled inflammatory response that can be derived from an effective control of parasite growth. Our findings suggest that ASY maintain a pool of IFN-γ-associated Th cell phenotypes that orchestrate the immune response, limiting parasitemia and preventing clinical malaria.